Controversia en torno a la criopreservación de sangre proveniente de cordón umbilical con fines autólogos y a nivel privado

Contenido principal del artículo

Pablo Argibay

Downloads

Download data is not yet available.

Detalles del artículo

Sección

Carta al editor

Cómo citar

1.
Argibay P. Controversia en torno a la criopreservación de sangre proveniente de cordón umbilical con fines autólogos y a nivel privado. Rev Hosp Ital B.Aires [Internet]. 2004 Dec. 10 [cited 2026 Apr. 26];24(2):42-4. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/1210

Referencias

Halban PA. Cellular sources of new pancreatic beta cells and thera-peutic implications for regenerative medicine. Nat Cell Biol 2004; 6(11):1021-5. DOI: https://doi.org/10.1038/ncb1104-1021

Broxmeyer HE, Douglas GW, Hangoc G y col. Human umbilical cordblood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828-32. DOI: https://doi.org/10.1073/pnas.86.10.3828

Jeong JA, Gang EJ, Hong SH y col. Rapid neural differentiation ofhuman cord blood-derived mesenchymal stem cells. Neuroreport 2004;15(11): 1731-4. DOI: https://doi.org/10.1097/01.wnr.0000134846.79002.5c

Jang YK, Park JJ, Lee MC y col. Retinoic acid-mediated induction ofneurons and glial cells from human umbilical cord-derived hematopoieticstem cells. J Neurosci Res 2004; 75(4): 573-84. DOI: https://doi.org/10.1002/jnr.10789

Ballen KK. New trends in umbilical cord blood transplantation. Blood[en línea] 2005 [marzo 2005] Disponible en: http://www.bloodjournal.org/cgi/reprint/2004-10-4125v1.

Steinbrook R. The cord-blood-bank controversies. N Engl J Med 2004351: 2255-225 DOI: https://doi.org/10.1056/NEJMp048283

Ver también pgs. 2265, 2276, 2328.7. Can routine commercial cord blood banking be scientifically andEthically Justified? PLoS Med 2005; 2(2): e44. DOI: https://doi.org/10.1371/journal.pmed.0020044

Vendrame M, Cassady J, Newcomb J y col. Infusion of human umbilicalcord blood cells in a rat model of stroke dose-dependently rescuesbehavioral deficits and reduces infarct volume. Stroke 2004; 35(10):2390-5. DOI: https://doi.org/10.1161/01.STR.0000141681.06735.9b

Taguchi A, Soma T, Tanaka H y col. Administration of CD34+ cellsafter stroke enhances neurogenesis via angiogenesis in a mouse model. JClin Invest 2004; 114(3): 330-8. DOI: https://doi.org/10.1172/JCI200420622

Ethical aspects of umbilical cord blood banking. Opinion of theEuropean Group on Ethics in Science and new Technologies to theEuropean Comisión. Boletín informativo. Marzo 16, 2004.

Del Pozo Gamba, Marcos. Editorial. Boletín de la Asociación Argentinade Hematoinmunología, sept. 2004.

Reems JA, Fujita D, Tyler T y col. Obtaining an accepted investigationalnew drug application to operate an umbilical cord blood bank. Transfusion1999; 39(4): 357-63. DOI: https://doi.org/10.1046/j.1537-2995.1999.39499235666.x

Sugarman J, Kaalund V, Kodish E y col. Ethical issues in umbilicalcord blood banking. Working Group on ethical issues in umbilical cordblood banking. JAMA 1997; 278(11): 938-43 DOI: https://doi.org/10.1001/jama.1997.03550110076040

Artículos más leídos del mismo autor/a

1 2 3 > >>